Minerva Neurosciences, Inc.NERVNASDAQ

52-Week Range1-12

1.15Current 6.5512.46

Want to monitor NERV?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

minerva neurosciences, inc.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Remy Luthringer

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Why is Broadcom warning of tighter supply in AI hardware?

ALSTOM S.A: Alstom will upgrade the Skyway at Houston Intercontinental Airport and continue operations and maintenance for 15 years

Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

White House to pay TotalEnergies $1 billion to kill off East Coast wind farm projects

UK homebuilder Bellway trims operating margin outlook for fiscal 2026

Autoliv and RS Taichi Partner to Advance Motorcycle Rider Protection with an Airbag Vest

ROSEN, LEADING INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

ROSEN, NATIONAL INVESTOR RIGHTS LAWYERS, Encourages Navan, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NAVN

Ford to recall over 254,600 U.S. vehicles over issues with assistance features, NHTSA says

Talphera, Inc. (TLPH) Analyst/Investor Day Transcript

1 Stock-Split Stock to Buy Before It Soars 63% According to a Wall Street Analyst

InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 24

Oracle Expands AI Agent Studio for Fusion Applications with Agentic Applications Builder and New Intelligent Workflow Tools

European stocks poised to lose ground as Iran war remains in focus

Oracle Introduces Fusion Agentic Applications

Star Copper Confirms Copper Creek Mineralization

Hi-View Amends Exploration Permit to Include High-Priority Porphyry Target Zones

Exor Swings to Net Loss as Listed Companies Hurt Results

Equinor ASA: Share buy-back – first tranche for 2026

Annual Report 2025: Cadeler Delivers Strong Financial Results While Doubling Fleet Capacity

About